tiprankstipranks
Trending News
More News >
Kuros Biosciences Ltd. (CH:KURN)
:KURN

Kuros Biosciences (KURN) Revenue

Compare
0 Followers

Kuros Biosciences Revenue

Kuros Biosciences had a revenue of 31.84M in the quarter ending Jun 30, 2024, with 53.85%. This bring the company's revenue in the last twelve months to 52.54M, Decreased 56.54%. In the fiscal year ending Dec 31, 2024, Kuros Biosciences had annual revenue of 75.56M with 125.11% growth.
Revenue (ttm)
52.54M
Revenue Growth
125.11%
P/S Ratio
13.61
Revenue/Employee
$619,303
Employees
122
Market Cap
$1.03B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202475.56M41.99M+125.11%
Dec 31, 202333.56M15.58M+86.61%
Dec 31, 202217.99M4.17M+30.19%
Dec 31, 202113.81M9.78M+242.04%
Dec 31, 20204.04M1.48M+57.71%
Dec 31, 20192.56M1.85M+258.18%
Dec 31, 2018715.00K181.00K+33.90%
Dec 31, 2017534.00K-527.00K-49.67%
Dec 31, 20161.06M-5.29M-83.30%
Dec 31, 20156.36M5.36M+535.50%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis